Many people with an aggressive blood cancer called diffuse large B cell lymphoma are cured by the current gold standard of ...
During a live event, Paolo Strati, MD and participants explored anti‑CD19 CAR T options for relapsed LBCL—including ...
Many people with an aggressive blood cancer called diffuse large B cell lymphoma are cured by the current gold standard of ...
In a large US cohort study, patients with primary cutaneous B-cell lymphoma (pCBCL) had significantly higher risks of developing hematologic and prostate cancers. Researchers analyzed data from 3757 ...
On top of the fear and grief in learning that you have an aggressive form of cancer, you’ll have many appointments, some directly related to your treatment and others to help you with the financial, ...
Diffuse large B-cell lymphoma is a common type of non-Hodgkin’s lymphoma that also has a high rate of relapse. Common signs of a relapse include lymph node swelling, as well as the development of “B ...
Hodgkin lymphoma and primary mediastinal B-cell lymphoma are two aggressive blood cancers that affect young people between their late teens and mid-30s, a group often referred to as Adolescents and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results